Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Challenges Involved in the Development and Delivery of Abuse-deterrent Formulations of Opioid Analgesics.

Cohen JP, Mendoza M, Roland C.

Clin Ther. 2018 Feb;40(2):334-344. doi: 10.1016/j.clinthera.2018.01.003. Epub 2018 Feb 3.

PMID:
29398162
2.

Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?

Cohen JP, Khoury CE, Milne CP, Peters SM.

Health Serv Res. 2018 Aug;53 Suppl 1:2758-2769. doi: 10.1111/1475-6773.12781. Epub 2017 Oct 18.

PMID:
29047143
3.

Too Big, Too Small, or Just Right? Cost-Efficiency of Environmental Inspection Services in Connecticut.

Cohen JP, Checko PJ.

Health Serv Res. 2017 Dec;52 Suppl 2:2285-2306. doi: 10.1111/1475-6773.12740. Epub 2017 Jul 20.

4.

Linking impaired skin barrier function to esophageal allergic inflammation via IL-33.

Travers J, Rochman M, Miracle CE, Cohen JP, Rothenberg ME.

J Allergy Clin Immunol. 2016 Nov;138(5):1381-1383. doi: 10.1016/j.jaci.2016.09.001. Epub 2016 Sep 21. No abstract available.

5.

Progress Report on Neglected Tropical Disease Drug Donation Programs.

Cohen JP, Silva L, Cohen A, Awatin J, Sturgeon R.

Clin Ther. 2016 May;38(5):1193-204. doi: 10.1016/j.clinthera.2016.02.031. Epub 2016 Mar 31.

PMID:
27041410
6.

Market watch: Where is personalized medicine in industry heading?

Milne CP, Cohen JP, Chakravarthy R.

Nat Rev Drug Discov. 2015 Dec;14(12):812-3. doi: 10.1038/nrd4759. Epub 2015 Oct 16. No abstract available.

PMID:
26471367
7.

Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry.

Milne CP, Cohen JP, Felix A, Chakravarthy R.

Clin Ther. 2015 Aug;37(8):1852-8. doi: 10.1016/j.clinthera.2015.05.514. Epub 2015 Jul 2.

PMID:
26143223
8.

Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent.

Cohen JP, Dong J, Lu CY, Chakravarthy R.

BMJ. 2015 Jul 3;351:h3333. doi: 10.1136/bmj.h3333. No abstract available.

PMID:
26141315
9.

Can genomic medicine improve financial sustainability of health systems?

Lu CY, Cohen JP.

Mol Diagn Ther. 2015 Apr;19(2):71-7. doi: 10.1007/s40291-015-0138-3. Review.

PMID:
25862552
10.

Implementing the affordable care act: remaining hurdles.

Cohen JP.

Clin Ther. 2015 Apr 1;37(4):717-9. doi: 10.1016/j.clinthera.2015.02.026. Epub 2015 Mar 23. No abstract available.

PMID:
25812972
11.

Roadblocks preventing personalized medicine from reaching its potential.

Cohen JP.

Biomark Med. 2015;9(1):5-8. doi: 10.2217/bmm.14.66. No abstract available.

PMID:
25605450
12.

Personalized Medicine's Bottleneck: Diagnostic Test Evidence and Reimbursement.

Cohen JP, Felix AE.

J Pers Med. 2014 Apr 4;4(2):163-75. doi: 10.3390/jpm4020163.

13.

Measuring progress in neglected disease drug development.

Cohen JP, Sturgeon G, Cohen A.

Clin Ther. 2014 Jul 1;36(7):1037-42. doi: 10.1016/j.clinthera.2014.05.004. Epub 2014 Jun 3.

PMID:
24906971
14.
15.

Are payers treating orphan drugs differently?

Cohen JP, Felix A.

J Mark Access Health Policy. 2014 Jan 15;2. doi: 10.3402/jmahp.v2.23513. eCollection 2014.

16.

Comparative-effectiveness research: does it matter?

Cohen JP.

Clin Ther. 2013 Apr;35(4):371-9. doi: 10.1016/j.clinthera.2012.12.018. Epub 2013 Mar 21.

PMID:
23523048
17.

Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Tilles SA, Borish L, Cohen JP.

Ann Allergy Asthma Immunol. 2013 Feb;110(2):70-4. doi: 10.1016/j.anai.2012.11.014. Epub 2012 Dec 17. No abstract available.

18.

Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).

Cohen JP, Ruha AM, Curry SC, Biswas K, Westenberger B, Ye W, Caldwell KL, Lovecchio F, Burkhart K, Samia N.

J Med Toxicol. 2013 Mar;9(1):9-15. doi: 10.1007/s13181-012-0272-9.

19.

Evaluating the impact of Medicare Part D on quality metrics.

Cohen JP.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):271-3. doi: 10.1586/erp.12.25.

PMID:
22812549
20.

Dynamics of the mental health workforce: investigating the composition of physicians and other health providers.

Stefos T, Burgess JF Jr, Cohen JP, Lehner L, Moran E.

Health Care Manag Sci. 2012 Dec;15(4):373-84. doi: 10.1007/s10729-012-9203-1. Epub 2012 Jun 22.

PMID:
22723031
21.

Overcoming regulatory and economic challenges facing pharmacogenomics.

Cohen JP.

N Biotechnol. 2012 Sep 15;29(6):751-6. doi: 10.1016/j.nbt.2012.02.001. Epub 2012 Feb 19. Review.

PMID:
22370122
22.

Health-care service utilization in substance abusers receiving contingency management and standard care treatments.

Olmstead TA, Cohen JP, Petry NM.

Addiction. 2012 Aug;107(8):1462-70. doi: 10.1111/j.1360-0443.2012.03831.x. Epub 2012 Apr 17.

23.

Personalized medicine: are payers the weak link?

Cohen JP.

Per Med. 2011 May;8(3):293-296. doi: 10.2217/pme.11.38. No abstract available.

PMID:
29783526
24.

International experience with comparative effectiveness research: case studies from England/Wales and Germany.

Bridges JF, Cohen JP, Grist PG, Mühlbacher AC.

Adv Health Econ Health Serv Res. 2010;22:29-50.

PMID:
20575227
25.

Assessing comparative effectiveness research in the US.

Cohen JP, Bridges JF.

Appl Health Econ Health Policy. 2009;7(4):219-24. doi: 10.2165/11530320-000000000-00000.

PMID:
19905035
26.

Substernal goiters and sternotomy.

Cohen JP.

Laryngoscope. 2009 Apr;119(4):683-8. doi: 10.1002/lary.20102.

PMID:
19160398
27.

Finding legitimacy for the role of budget impact in drug reimbursement decisions.

Niezen MG, de Bont A, Busschbach JJ, Cohen JP, Stolk EA.

Int J Technol Assess Health Care. 2009 Jan;25(1):49-55. doi: 10.1017/S0266462309090072.

PMID:
19126251
28.

Role of budget impact in drug reimbursement decisions.

Cohen JP, Stolk E, Niezen M.

J Health Polit Policy Law. 2008 Apr;33(2):225-47. doi: 10.1215/03616878-2007-054.

PMID:
18325899
29.

Cost-effectiveness and resource allocation.

Cohen JP.

JAMA. 2006 Jun 21;295(23):2723; author reply 2723-4. No abstract available.

PMID:
16788126
30.

Switching prescription drugs to over the counter.

Cohen JP, Paquette C, Cairns CP.

BMJ. 2005 Jan 1;330(7481):39-41. No abstract available.

31.

The ozone formation potential of 1-bromo-propane.

Whitten GZ, Cohen JP, Myers TC, Carter WP.

J Air Waste Manag Assoc. 2003 Mar;53(3):262-72.

PMID:
12661686
32.

PBMs and a Medicare prescription drug benefit.

Cohen JP.

Food Drug Law J. 2000;55(3):311-20. No abstract available.

PMID:
11824463
33.

National estimates of outdoor air toxics concentrations.

Rosenbaum AS, Axelrad DA, Woodruff TJ, Wei YH, Ligocki MP, Cohen JP.

J Air Waste Manag Assoc. 1999 Oct;49(10):1138-52.

PMID:
10616743
34.

[Gastric necrosis after a bulimia episode in an anorectic patient].

Jacquot S, Lamy P, Cohen JP, Le Quintrec Y.

Presse Med. 1989 Nov 25;18(39):1932. French. No abstract available.

PMID:
2531875
35.

Susceptibility to influenza A in HIV-positive patients.

Cohen JP, Macauley C.

JAMA. 1989 Jan 13;261(2):245. No abstract available.

PMID:
2909018
36.
37.

[Bilio-biliary fistulas of lithiasic origin. Apropos of 8 cases].

Halleb A, Frileux P, Cohen JP, Hannoun L, Nordlinger B, Parc R, Loygue J.

Ann Chir. 1986 Sep;40(6):363-6. French. No abstract available.

PMID:
3592543
38.

Management of substernal and intrathoracic goiters.

Cho HT, Cohen JP, Som ML.

Otolaryngol Head Neck Surg. 1986 Mar;94(3):282-7.

PMID:
3083354
39.

Internal jugular vein thrombosis.

Cohen JP, Persky MS, Reede DL.

Laryngoscope. 1985 Dec;95(12):1478-82.

PMID:
4068866
40.

[Congenital dilatation of the liver and common bile duct. Apropos of a case in an adult].

Cohen JP, Balladur A, Faye A.

Ann Chir. 1985 Jun;39(5):330-2. French. No abstract available.

PMID:
4037660
41.

Reversible facial paralysis in sarcoidosis. Confirmation by serum angiotensin-converting enzyme assay.

Cohen JP, Lachman LJ, Hammerschlag PE.

Arch Otolaryngol. 1983 Dec;109(12):832-5.

PMID:
6314956
42.

Carbonic anhydrase localization in the epidimymis and testis of the rat: histochemical and biochemical analysis.

Cohen JP, Hoffer AP, Rosen S.

Biol Reprod. 1976 Apr;14(3):339-46. No abstract available.

PMID:
814936
43.

[Bird-head dyscephaly (Hallermann-Streiff-Francois syndrome)].

LARMANDE A, GILLOT F, DALAUT JJ, COHEN JP, SCHAEFFER JC.

Pediatrie. 1962;17:313-6. French. No abstract available.

PMID:
14462442
44.

[Apropos of a case of situs inversus].

GILLOT F, de PERETTI, COHEN JP.

Pediatrie. 1960;15:457-60. French. No abstract available.

PMID:
13850146

Supplemental Content

Loading ...
Support Center